This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Khalil A, Zaidman I, Elhasid R, Peretz-Nahum M, Futerman B, Ben-Arush M. Factors influencing outcome and incidence of late complications in children who underwent allogeneic hematopoietic stem cell transplantation for hemoglobinopathy. Pediatr Hematol Oncol. 2012;29:694–703.
De Sanctis V. Growth and puberty and its management in thalassaemia. Horm Res. 2002;58(Suppl 1):72–9.
Li CK, Chik KW, Wong GW, Cheng PS, Lee V, Shing MM. Growth and endocrine function following bone marrow transplantation for thalassemia major. Pediatr Hematol Oncol. 2004;21:411–9.
Aldemir-Kocabas B, Tezcan-Karasu G, Bircan I, Bircan O, Aktas-Samur A, Yesilipek MA. Evaluating the patients with thalassemia major for long-term endocrinological complications after bone marrow transplantation. Pediatr Hematol Oncol. 2014;31:616–23.
Kattamis AC, Antoniadis M, Manoli I, Kitra V, Petropoulos D, Grafakos S. Endocrine problems in ex-thalassemic patients. Transfus Sci. 2000;23:251–2.
Lam WW, Au WY, Chu WC, Tam S, Ha SY, Pennell DJ. One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients. J Magn Reson Imaging. 2008;28:29–33.
Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045–52.
Buchanan JD, Fairley KF, Barrie JU. Return of spermatogenesis after stopping cyclophosphamide therapy. Lancet. 1975;2:156–7.
De Simone M, Olioso P, Di Bartolomeo P, Di Girolamo G, Farello G, Palumbo M, et al. Growth and endocrine function following bone marrow transplantation for thalassemia. Bone Marrow Transplant. 1995;15:227–33.
Savani BN, Griffith ML, Jagasia S, Lee SJ. How I treat late effects in adults after allogeneic stem cell transplantation. Blood. 2011;117:3002–9.
Chirico V, Rigoli L, Lacquaniti A, Salpietro V, Piraino B, Amorini M, et al. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment. Eur J Haematol. 2015;94:404–12.
Oudit GY, Trivieri MG, Khaper N, Liu PP, Backx PH. Role of L-type Ca2 + channels in iron transport and iron-overload cardiomyopathy. J Mol Med. 2006;84:349–64.
Watanabe H, Ma M, Washizuka T, Komura S, Yoshida T, Hosaka Y, et al. Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem Biophys Res Commun. 2003;308:439–44.
Yu Z, Wang T, Xu L, Huang CX. Thyroid hormone increased L-type calcium channel mRNA expression and L-type calcium current of myocytes in rabbits. Bio-Med Mater Eng. 2012;22:49–55.
Cheuk DK, Mok AS, Lee AC, Chiang AK, Ha SY, Lau YL, et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant. 2008;42:319–27.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
See, Ws.Q., Tung, J.Yl., Cheuk, D.Kl. et al. Endocrine complications in patients with transfusion-dependent thalassaemia after haemopoietic stem cell transplantation. Bone Marrow Transplant 53, 356–360 (2018). https://doi.org/10.1038/s41409-017-0052-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41409-017-0052-x
This article is cited by
-
Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/β-thalassemia and those achieving successful hematopoietic stem-cell transplantation
International Journal of Hematology (2022)
-
Busulfan/cyclophosphamide
Reactions Weekly (2018)